SB1466 99TH GENERAL ASSEMBLY

LRB099 09990 AMC 30210 b

99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
SB1466

Introduced 2/20/2015, by Sen. Donne E. Trotter

SYNOPSIS AS INTRODUCED:

225 ILCS 85/19.1 new

Amends the Pharmacy Practice Act. Allows a licensed pharmacist to dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department of Financial and Professional Regulation, in consultation with the Department of Public Health, if such procedures or protocols are filed at the pharmacist's place of practice and with the Board of Pharmacy before implementation. Requires the pharmacist to complete a training program approved by the Department of Human Services under the Drug Overdose Prevention Program authorized under Alcoholism and Other Drug Abuse and Dependency Act. Defines "opioid antagonist". Effective immediately.

FISCAL NOTE ACT MAY APPLY

A BILL FOR

AN ACT concerning regulation.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Pharmacy Practice Act is amended by adding Section 19.1 as follows:

(225 ILCS 85/19.1 new)

Sec. 19.1. Dispensing opioid antagonists.

(a) Due to the recent rise in opioid-related deaths in Illinois and the existence of an opioid antagonist that can reverse the deadly effects of overdose, the General Assembly finds that in order to avoid further loss where possible, it is responsible to allow greater access of such an antidote to those populations at risk of overdose.

(b) Notwithstanding any general or special law to the contrary, a licensed pharmacist may dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department, in consultation with the Department of Public Health, if such procedures or protocols are filed at the pharmacist's place of practice and with the Board before implementation.

(c) Before dispensing an opioid antagonist pursuant to this Section, a pharmacist shall complete a training program approved by the Department of Human Services under the Drug Overdose Prevention Program authorized under Section 5-23 of the Alcoholism and Other Drug Abuse and Dependency Act. The training program shall include, but not be limited to, proper documentation and quality assurance.

(d) For the purpose of this Section, "opioid antagonist" means a dose of naloxone hydrochloride or any other similarly acting and equally safe drug approved by the United States Food and Drug Administration.

Section 99. Effective date. This Act takes effect upon becoming law.